AZD8055-mediated mTOR blockade efficiently delayed tumor growth resulting in prolonged tumor-specific survival (Fig. 6, A and B), in agreement with the observed tumoristasis in AZD8055-treated KEP tumors (Klarenbeek et al., 2020). The gene discussed is MTOR; the disease is neoplasm.